Tenet Healthcare (THC) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $22.43B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | US | CEO | Saumya Sutaria |
| IPO Date | 1980-03-17 | CAGR | 5.26% |
| Employees | 88,500 | Website | www.tenethealth.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.69% | Total Yield | 0.69% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $29.05B | P/E | 16.16 | Forward P/E | 13.37 | PEG | 0.05 |
| P/S | 10.76 | P/B | 49.17 | P/CF | 57.24 | P/FCF | 78.26 |
| Sales | $21.81B | Sales 1Y | 5.43% | Sales 3Y | 9.64% | Sales 5Y | 13.56% |
| EPS | $17.24 | EPS 1Y | 66.01% | EPS 3Y | 469.89% | EPS 5Y | 548.25% |
| Sales QoQ | 4.84% | EPS QoQ | 22.85% | Sales QoQ Avg | 1.7% | EPS QoQ Avg | 36.23% |
| Gross Margin | 26.87% | Operating Margin | 16.8% | Profit Margin | 10.27% | ROCE | 14.59% |
| ROA | 7% | ROE | 51% | Altman Z Score | 2.13 | Piotroski Score | 7 |
| Current Ratio | 1.41 | Quick Ratio | 1.35 | Cash Ratio | 0.39 | Op. CF Ratio | 0.11 |
| Debt/Equity | 2.84 | Debt/Assets | 0.43 | Lt Debt/Equity | 2.81 | Lt Debt/Cap. | 0.74 |
| Intrst Cov. | 4.47 | Inventory Turnover | 47.2 | Asset Turnover | 0.71 | Receivables Turnover | 8.36 |
| Enterprise Value | $29.05B | P/E Ratio | 16.16 |
| Forward P/E | 13.37 | PEG Ratio | 0.05 |
| P/S Ratio | 10.76 | P/B Ratio | 49.17 |
| P/CF Ratio | 57.24 | P/FCF Ratio | 78.26 |
| EPS | $17.24 | EPS Growth 1Y | 66.01% |
| EPS Growth 3Y | 469.89% | EPS Growth 5Y | 548.25% |
| Revenue Growth 1Y | 5.43% | Gross Margin | 0.27% |
| Operating Margin | 0.17% | Profit Margin | 0.1% |
| ROE | 0.51% | ROA | 0.07% |
| ROCE | 0.15% | Current Ratio | 1.41 |
| Quick Ratio | 1.35 | Cash Ratio | 0.39 |
| Debt/Equity | 2.84 | Interest Coverage | 4.47 |
| Altman Z Score | 2.13 | Piotroski Score | 7 |
Tenet Healthcare (THC) valuation & financials
Tenet Healthcare (THC) has a market capitalization of $22.43B and trades at a price-to-earnings ratio of 16.2. It operates in the Healthcare sector (Medical - Care Facilities).
Tenet Healthcare's revenue grew +5.4% over the last year.
Tenet Healthcare's next earnings report is scheduled for October 27, 2026 before market open; analysts estimate EPS of $4.64. Check the earnings calendar to see all companies reporting this week.
Tenet Healthcare (THC) — frequently asked questions
When does Tenet Healthcare (THC) report earnings next?
Tenet Healthcare is expected to report earnings on October 27, 2026 before market open. Analysts estimate EPS of $4.64.
What is Tenet Healthcare's market cap?
Tenet Healthcare (THC) has a market capitalization of $22.43B.
What is THC's P/E ratio?
Tenet Healthcare trades at a price-to-earnings ratio of 16.2, with trailing twelve-month EPS of $17.24.
How fast is Tenet Healthcare growing?
Tenet Healthcare's revenue grew +5.4% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)